| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 679 | 33.705 | 69.800 | 57.379 | 105.919 | 130.981 | 153.858 | 236.628 |
| Total Income - EUR | - | - | 679 | 33.709 | 69.805 | 57.379 | 105.919 | 130.982 | 154.751 | 241.414 |
| Total Expenses - EUR | - | - | 277 | 959 | 1.560 | 6.176 | 8.080 | 5.483 | 17.644 | 19.365 |
| Gross Profit/Loss - EUR | - | - | 401 | 32.749 | 68.244 | 51.203 | 97.839 | 125.498 | 137.107 | 222.049 |
| Net Profit/Loss - EUR | - | - | 381 | 31.738 | 66.150 | 49.566 | 94.662 | 122.302 | 135.559 | 214.855 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Flebartis Vd Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 11 | 0 | 0 | 1.386 | 461 | 18 | 524 | 1.106 |
| Current Assets | - | - | 565 | 32.593 | 98.111 | 144.096 | 213.261 | 140.296 | 139.450 | 233.718 |
| Inventories | - | - | 0 | 0 | 0 | 2.695 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 4.208 | 3.836 | 0 | 7.977 | 9.459 | 10.624 | 214.773 |
| Cash | - | - | 565 | 28.385 | 94.274 | 141.401 | 205.284 | 130.837 | 128.826 | 18.945 |
| Shareholders Funds | - | - | 425 | 32.155 | 92.625 | 135.060 | 94.710 | 132.443 | 135.608 | 214.903 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 152 | 438 | 5.486 | 10.422 | 119.012 | 7.871 | 4.366 | 19.921 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Flebartis Vd Medical Srl